dr keller glutathione accelerator Darren B. 1_A4M Cover.indd
Description
Khrunin et al showed that 104 patients with ovarian cancer with mutant-type GST possessed longer progression-free survival compared to wild-type GST
By better understanding GSHs mechanism and effects, we may be able to make stronger recommendations for GSH supplementation as a targeted adjunct or solo therapy option in various patient subgroups
Addition of a nonionic detergent also may improve solubilization and minimize any aggregation that may be occurring
Each dose delivers: - 2.5 mg GHK-Cu - 0.5 mg BPC-157 - 0.5 mg TB-4 - 0.5 mg KPV Two to three milliliters covers the standard setups
